ArticleCold Spring Harbor molecular case studies2021

Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed

Tingting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.